Short Abstract

The reaction of chromium(VI) with four thiols, b-mercaptoethanol, dithiothreitol, glutathione, and cysteine at pH 7.0 and 37 °C was studied in order to determine differences in their reactions with chromium(VI). It was shown that the reduction of chromium(VI) by cysteine and glutathione was very fast, and very little chromium(V) was detectable. Reduction of chromium(VI) by b-mercaptoethanol or dithiothreitol, however, proceeded much more slowly, and relatively large levels of chromium(V) were detectable. All chromium(V) species observed displayed EPR spectra indicative of complexes possessing axial geometries. The presence of DNA or chelating agents in reactions involving b-mercaptoethanol resulted in a large increase in chromium(V) concentration seen over time. It was shown that the levels of chromium(V) formed in the presence of the four thiols studied is related to the amount of chromium bound to DNA in the presence of these thiols.

The reduction of chromium(VI) by ethanethiol, propanethiol, dimercaptosuccinic acid, and glutathione, typically lead to the formation of thiyl radical, whereas reduction by cysteine and cysteamine led to formation of hydroxyl radical. Reduction of chromium(VI) by ethanethiol, propanethiol, dimercaptosuccinic acid, or glutathione, also led to the formation of chromium(V). Reaction of ethanethiol or propanethiol with chromium(VI) resulted in the formation of very similar chromium(V) species, and the presence of 5,5-dimethyl-1-pyrroline-N-oxide in these reactions altered the relative intensities of the chromium(V) species formed. It has been proposed that this may be due to removal of reactive radical species from the reaction sphere by 5,5-dimethyl-1-pyrroline-N-oxide.

The reaction of bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) or bis(2-hydroxy-2-methylbutyrato)oxochromate(V) with reducing agents such as b-mercaptoethanol, dithiothreitol, glutathione, oxidized glutathione, thioglycolic acid, glycine, oxalic acid, and ascorbic acid was studied. In non-aqueous solvents where reduction was retarded, reactions between the initial chromium(V) complex and dithiothreitol or thioglycolic acid resulted in ligand substitution, and the formation of mono- or bis-(thiol)chromium(V) complexes.

Abstract

The overall goal of this research has been to illuminate the possible fate of chromium(VI) and chromium(V) in biological systems, by studying in vitro reactions of chromium(VI) and chromium(V) with low molecular weight biological and model reductants, as a means of more fully understanding the processes involved in the genotoxicity of chromium. The main tool for this study has been Electron Paramagnetic Resonance Spectroscopy

The reaction of chromium(VI) with four thiols, b-mercaptoethanol, dithiothreitol, glutathione, and cysteine at pH 7.0 and 37 °C was studied in order to determine differences in their reactions with chromium(VI). These experiments have revealed important structural and rate information on the chromium species formed during these reactions. Specifically, all chromium(V) species observed displayed EPR spectra indicative of complexes possessing axial geometries. It was shown that the reduction of chromium(VI) by cysteine and glutathione was very fast, with most of the chromium(VI) reduced to chromium(III) within 2 minutes, and very little chromium(V) was detectable. Reduction of chromium(VI) by b-mercaptoethanol or dithiothreitol, however, proceeded much more slowly, and relatively large levels of chromium(V) were detectable. The reaction of b-mercaptoethanol with chromium(VI) in the presence of DNA or chelating agents resulted in a large increase in chromium(V) concentration seen over time, vs. reactions of b-mercaptoethanol and chromium(VI) alone. It was shown that the levels of chromium(V) formed in the presence of the four thiols studied is related to the amount of chromium bound to DNA in the presence of these thiols. Dithiothreitol and b-mercaptoethanol produced very high levels of chromium-DNA adducts and also produced high levels of chromium(V), whereas much lower levels of both chromium-DNA adducts and chromium(V) were produced with glutathione and cysteine.

The reduction of chromium(VI) by thiols, i.e., ethanethiol, propanethiol, dimercaptosuccinic acid, and glutathione, typically lead to the formation of thiyl (•SR) radical, and in the cases of cysteine and cysteamine to the formation of hydroxyl (•OH) radical. For the thiols ethanethiol, propanethiol, dimercaptosuccinic acid, or glutathione, the rate of the overall chromium(VI) Æ chromium(III) reduction was slower than for cysteine or cysteamine, and the formation of chromium(V) was observed in the EPR spectra. Reaction of ethanethiol or propanethiol with chromium(VI) resulted in the formation of very similar chromium(V) species, and the presence of 5,5-dimethyl-1-pyrroline-N-oxide in these reactions altered the relative intensities of the chromium(V) species formed. It has been proposed that this may be due to removal of reactive radical species from the reaction sphere by 5,5-dimethyl-1-pyrroline-N-oxide.

The reaction of bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) or bis(2-hydroxy-2-methylbutyrato)oxochromate(V) with reducing agents such as b-mercaptoethanol, dithiothreitol, glutathione, oxidized glutathione, thioglycolic acid, glycine, oxalic acid, and ascorbic acid was studied. It was shown that in most cases reduction occurred before any appreciable ligand substitution on the chromium(V) center took place. However, especially in non-aqueous solvents where reduction was retarded, reactions between the initial chromium(V) complex and dithiothreitol or thioglycolic acid resulted in ligand substitution, and the formation of mono- or bis-(thiol)chromium(V) complexes.

Acknowledgments

This thesis is due in large part to Professor Karen Wetterhahn, and I would like to thank her for her guidance through my graduate student years. I am very fortunate to have had her as a mentor and scientific role-model; her knowledge, expertise, and dedication to science is inspiring and is a goal I will have to strive for many, many years to approach.

The Wetterhahn research group, Jayshree Aiyar, Joy Alcedo, Kim Borges, Holly Berkovitz, Andrew Standeven, Josh Hamilton, and Sam Brauer have all been great to work with; Jayshree, Joy and Kim have been especially helpful with biochemistry-related questions, and have taught me not a few techniques.

Most of this work involved EPR spectroscopy, and I would like to give thanks to Wayne Casey for doing a great job keeping the EPR equipment up and running; without his help with the hardware I could not have completed this work. In a similar vein, Professor Dean Wilcox has been especially helpful in answering my questions about EPR spectroscopy in general.

The other members of my committee, Professors Russell Hughes, Gordon Gribble, and Thomas Curphey have given me very helpful and insightful comments through the years. Professor Robert Cantor (Dr. Bob) has been quite helpful with my many computer/programming questions, and also was kind enough to agree to be a substitute on my committee.

I can thank my high school science teacher, Sister Carol Anne Murray, for believing in me and fostering my interest in science. She is the most dedicated teacher I have ever had, and she had the sense to push me to do my best. Thanks for the kicks in the pants when I needed them!

I would like to give special thanks to Kathy Winant who was always there for me, even when she had to bear the brunt of my moodiness during this thesis writing- her support and encouragement has meant a lot.

Finally, I would like to thank my parents, Phillip and Janet Boswell, my brother Eric and his wife Diane, and my grandmother Eveline Pelletier for all their support. Their faith in me has allowed me to come this far.

Table of Contents

Short Abstract ii

Abstract iv

Ackowledgements vi

Table of Contents viii

List of Tables xiv

List of Figures xv

Abbreviations xxix

1. INTRODUCTION 1

1.1. General 1

1.2. Biological Aspects of Chromium 1

1.2.1. Exposure 1

1.2.2. Carcinogenicity and Toxicity 2

1.3. Chromium(VI), d0 5

1.3.1. Reduction of Chromium(VI) 6

1.3.1.1. Cysteine and other thiols 8

1.3.1.2. Metals 9

1.3.1.2.1 Iron(II) 11

1.3.1.2.2 Vanadium(III) and Vanadium(IV) 12

1.3.1.2.3 Arsenic(III) 13

1.3.1.2.4 Molybdenum(IV) 13

1.4. Chromium(V), d1 15

1.4.1. Electron Paramagnetic Resonance 16

1.4.2. Reduction of Chromium(V) 18

1.4.2.1. Metals 18

1.4.2.1.1 Polyvalent metal ions 18

1.4.2.1.2 Titanium(III) 21

1.4.2.1.3 Iron(II), Vanadium(IV) 22

1.4.2.1.4 Uranium(IV) 24

1.4.2.1.5 Summary 24

1.4.2.2. Thiols 25

1.5. Goals of this Research 26

2 MATERIALS AND METHODS 28

2.1 Materials 28

2.2 Methods 29

2.2.1 Electron Paramagnetic Resonance Spectroscopy 29

2.2.1.1 Chromium(V) concentration determination. 29

2.2.1.2 Frozen glass studies (77 K) 30

2.2.1.3 Solution studies (297 K) 30

2.2.2 Electron Paramagnetic Resonance Detection of Chromium(V) and Chromium(III) Species Formed During the Reduction of Chromium(VI) by Thiols in the Presence or Absence of DNA 31

2.2.2.1 Synthesis of Na[Cr(L-cys)2]•2H2O 31

2.2.3 Electron Paramagnetic Resonance Detection of Chromium(V) and Radical Species Formed During the Reduction of Chromium(VI) by b-mercaptoethanol in the presence of chelating (DES, DETAPAC) and spin-trapping (DMPO) agents. 32

2.2.3.1 Purification of DMPO 32

2.2.4 Electron Paramagnetic Resonance Study of the Reaction of Chromium(VI) with Reducing Agents in the Presence of a Spin-Trap 33

2.2.5 Electron Paramagnetic Resonance Study of the Reaction of Chromium(V) Species with Reducing Agents 33

2.2.5.1 Synthesis of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) 36

2.2.5.2 Synthesis of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) 37

3. Electron Paramagnetic Resonance Detection of Chromium(V) and Chromium(III) Species Formed During the Reduction of Chromium(VI) By Thiols 38

3.1. Results and Discussion 38

3.1.1. Reaction of Chromium(VI) with b-mercaptoethanol 38

3.1.1.1. Discussion 41

3.1.1.2. Reaction of Chromium(VI) with b-mercaptoethanol in the presence of DNA 42

3.1.1.2.1 Discussion 44

3.1.1.3. Effect of DETAPAC, DES, and DMPO on the Reaction of Chromium(VI) with b-mercaptoethanol 47

3.1.1.3.1 Discussion 52

3.1.1.4. Summary of the Reduction of Chromium(VI) by b-mercaptoethanol 58

3.1.2. Reaction of Chromium(VI) with Dithiothreitol 59

3.1.2.1. Discussion 60

3.1.2.2. The Reaction of Chromium(VI) with Dithiothreitol in the Presence of DNA 62

3.1.2.2.1 Discussion 63

3.1.2.3. Summary of the Reduction of Chromium(VI) by Dithiothreitol 65

3.1.3. Reaction of Chromium(VI) with Glutathione 65

3.1.3.1. Discussion 67

3.1.3.2. Reaction of Chromium(VI) with Glutathione in the Presence of DNA 69

3.1.3.2.1 Discussion 70

3.1.3.3. Summary of the Reduction of Chromium(VI) by Glutathione 71

3.1.4. Reaction of Chromium(VI) with Cysteine 71

3.1.4.1. Discussion 73

3.1.4.2. Reaction of Chromium(VI) and Cysteine in the Presence of DNA 75

3.1.4.2.1 Discussion 76

3.1.4.3. Summary of the Reduction of Chromium(VI) by Cysteine 76

3.1.5. Summary of Reduction of Chromium(VI) by Thiols 77

3.1.6. Comparison of the Chromium(III) Products Formed During the Reaction of Chromium(VI) or Chromium(III) with Thiols 78

3.1.6.1. Chromium(III) vs. Chromium(V) EPR Spectroscopy 78

3.1.6.2. Chromium Reactions with Thiols 80

3.1.7. Correlation of Chromium(V) Formation with Chromium-DNA Binding During the Reaction of Chromium(VI) with Thiols 84

4. Electron Paramagnetic Resonance Study of the Reaction of Chromium(VI) with Reducing Agents in the Presence of a Spin-Trap 167

4.1. Spin Trapping 167

4.2. Results and Discussion 168

4.2.1. Cysteine 168

4.2.1.1. Discussion 169

4.2.2. Cysteamine 172

4.2.2.1. Discussion 173

4.2.3. Ethanethiol 174

4.2.3.1. Discussion 175

4.2.4. Propanethiol 176

4.2.4.1. Discussion 177

4.2.5. Dimercaptosuccinic acid 178

4.2.5.1. Discussion 179

4.2.6. Glutathione 183

4.2.6.1. Discussion 183

4.2.7. Ascorbic Acid 184

4.2.7.1. Discussion 185

4.2.8. Summary 187

5. Electron Paramagnetic Resonance Study of the Reaction of Chromium(V) Species with Reducing Agents 212

5.1. Results and Discussion 212

5.1.1. b-mercaptoethanol 212

5.1.1.1. Discussion 217

5.1.2. Dithiothreitol 218

5.1.2.1. Discussion 222

5.1.3. Glutathione 224

5.1.3.1. Discussion 226

5.1.4. Oxidized Glutathione 227

5.1.4.1. Discussion 227

5.1.5. Glycine 228

5.1.5.1. Discussion 228

5.1.6. Oxalic Acid 228

5.1.6.1. Discussion 230

5.1.7. Ascorbic Acid 231

5.1.7.1. Discussion 232

5.1.8. Thioglycolic Acid 233

5.1.8.1. Discussion 235

5.2. Summary 236

6. Summary of Results and Implications for Chromium(VI) Carcinogenesis 326

Appendix 334

References 344

List of Tables

Table 1-1. Reduction potentials, structures, and second order rate constants (pH 7.4 and 25 °C) for the reactions between chromate and a number of thiols, dithiols, and ascorbate 10

Table 1-2. Reduction potentials for various metal ions discussed in the text 15

Table 1-3. Reduction of chromium(V) chelate [Cr(V)(EHBA)2O]- by various metal ions in aqueous media, pH 2-4. Lig = 2-ethyl-2-hydroxybutyrate, (EHBA). 25

Table 3-1. EPR spectral parameters for the chromium(V) and radical species formed in the reaction of b-mercaptoethanol (9.6 mM) with chromium(VI) (0.48 mM) in the presence of DNA (0.048 mM), DETAPAC (0.48 mM), or DES (0.48 mM) in 50 mM Tris-HCl, pH 7.0. 53

Table 3-2. Chromium(V) complexes formed during the reduction of Chromium(VI) by thiols. 78

Table 3-3. EPR spectral parameters for chromium(III) complexes formed upon reaction of chromium(III)/chromium(VI) with thiols. 83

Table 4-1. EPR signals (297 K) observed during the reduction of chromium(VI) by various reducing agents in the presence or absence of DMPO and in Tris-HCl, cacodylic acid, or unbuffered solutions. 210

Table 5-1. EPR spectral parameters for the chromium(V) signals observed upon reaction of chromium(V) complexes with reducing agents in various solvents. 323

List of Figures

Figure 1-1. The "uptake-reduction" model for chromium(VI) carcinogenicity. 4

Figure 1-2. Structures of hydrogen chromate, HCrO4-, chromate, CrO42-, and dichromate, Cr2O72- 5

Figure 1-3. Diagram showing the predominant chromium(VI) species in aqueous solution at 25 °C and I = 1 M. 6

Figure 1-4. Structure of dimeric molybdenum(V) cation used by Ghosh and Gould for the reduction of chromium(VI) in aqueous solutions 15

Figure 1-5. Structure of chromium(V) chelate of tertiary hydroxy acids. Sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) ([Cr(V)(EHBA)2O] 16

Figure 1-6. Computer-generated (see program EPRsim, Appendix A) representative 77K EPR spectra for chromium(V) complexes with various structural differences. 19

Figure 1-7. Proposed structure of the final chromium(III) species produced by the reduction of [Cr(V)(EHBA)2O]- by Ti(III) (aqueous solution at low pH, m = 0.5 M, 25 °C) (Reaction [1-40]) 22

Figure 3-1 Structures of four of the thiol compounds used in this study. Probable ligating groups are indicated by an asterisk. 40

Figure 3-2. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (1.44, 2.4, 4.8 or 9.6 mM) 88

Figure 3-3. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and b-mercaptoethanol (1.44 - 9.6 mM) in 0.050 M Tris-HCl, pH 7.0 at 37 °C. 90

Figure 3-4. EPR spectra of chromium(III) complexes formed upon reaction of either chromium(III) or chromium(VI) with b-mercaptoethanol. Spectra were obtained upon reaction of chromium(III) nitrate (0.48 mM chromium(III)) with b-mercaptoethanol (9.6 mM) 92

Figure 3-5. Comparison of the EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (1.44-9.6 mM) 94

Figure 3-6. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and b-mercaptoethanol (1.44 - 9.6 mM) in the presence or absence of double-stranded CT DNA. 96

Figure 3-7. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 98

Figure 3-8. Time courses for formation of two separate chromium(V) species during the reaction of potassium dichromate (0.48 mM chromium(VI)) and b-mercaptoethanol (9.6 mM) in the presence of double-stranded CT DNA. 100

Figure 3-9. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 102

Figure 3-10. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and b-mercaptoethanol (9.6 mM) in the presence of CT DNA (0.003-0.048 mM), poly(dG) (0.048 mM), 5'dGMP (0.048 mM), or absence of DNA. 104

Figure 3-11. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and b-mercaptoethanol (9.6 mM) in the presence or absence of double-stranded CT DNA or DETAPAC. 106

Figure 3-12. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 108

Figure 3-13. EPR spectra of chromium(V) (A) or DMPO-radical adduct (B) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 110

Figure 3-14. EPR spectra of chromium(V) (A) or DMPO-radical adduct (B) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 112

Figure 3-15. Computer simulation study of the EPR spectra of DMPO-radical adduct complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 114

Figure 3-16. Comparison of the RT EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 116

Figure 3-17. EPR spectra of chromium(V) (A) or DMPO-radical adduct (B) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 118

Figure 3-18. Comparison of the EPR signal intensities of (A) chromium(V) and (B) DMPO-radical adduct complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with b-mercaptoethanol (9.6 mM) 120

Figure 3-19. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with dithiothreitol (1.44, 2.4, 4.8, or 9.6 mM) 122

Figure 3-20. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and dithiothreitol (1.44 - 9.6 mM) in 0.05 M Tris-HCl, pH 7.0 at 37 °C. 124

Figure 3-21. EPR spectra of chromium(III) complexes formed upon reaction of either chromium(III) or chromium(VI) with dithiothreitol. 126

Figure 3-22. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with dithiothreitol (1,44, 2.4, 4.8, or 9.6 mM) 128

Figure 3-23. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and dithiothreitol 130

Figure 3-24. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with dithiothreitol (9.6 mM) 132

Figure 3-25. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and dithiothreitol (9.6 mM) in the presence of poly(dG) (0.048 mM) 134

Figure 3-26. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with glutathione (1.44-9.6 mM) 136

Figure 3-27. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and glutathione(1.44 - 9.6 mM) in 0.05 M Tris-HCl, pH 7.0 at 37 °C. 138

Figure 3-28. EPR spectra of chromium(III) complexes formed upon reaction of either chromium(III) or chromium(VI) with glutathione. 140

Figure 3-29. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with glutathione (9.6 mM) 142

Figure 3-30. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and glutathione (9.6 mM) in the presence of double-stranded calf thymus DNA (0.048 mM) 144

Figure 3-32. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and cysteine (1.44 - 9.6 mM) in 0.05 M Tris-HCl, pH 7.0 at 37 °C. 148

Figure 3-33. EPR spectra of chromium(III) complexes formed upon reaction of either chromium(III) or chromium(VI) with cysteine. 150

Figure 3-34. EPR spectra of potassium dichromate (0.48 mM chromium(VI)) incubated with cysteine (9.6 mM) 152

Figure 3-35. Electronic spectrum of potassium dichromate (0.48 mM chromium(VI)) incubated with cysteine (9.6 mM) 154

Figure 3-36. EPR spectra of chromium(V) complexes formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with cysteine (9.6 mM) 156

Figure 3-37. Time courses for chromium(V) formation during the reaction of potassium dichromate (0.48 mM chromium(VI)) and cysteine (9.6 mM) in the presence of double-stranded calf thymus DNA (0.048 mM) 158

Figure 3-38. EPR spectra of chromium(III) complex formed upon reaction of potassium dichromate (0.48 mM chromium(VI)) with cysteine (9.6 mM) 160

Figure 3-39. Energy level diagram showing the effect of zero field splittings on the fields at which the DMs = 1 transitions occur in an S = 3/2 system 162

Figure 3-40. EPR spectra observed upon reaction of Cr(NO3)3•9H2O (0.475 mM) with b-mercaptoethanol. dithiothreitol, glutathione, or cysteine (9.6 mM) 163

Figure 3-41. Proposed structures of the chromium(III)-thiol complexes formed upon incubation of hexaaquochromium(III) with (A) dithiothreitol, (B) b-mercaptoethanol, and (C) glutathione. 165

Figure 3-42. Crystal structure of the [Cr(L-cys)2]- anion in Na[Cr(L-cys)2]•2H2O. 166

Figure 4-1. Structures of the reducing agents used in this study. 189

Figure 4-2. The reaction of 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) (Diamagnetic), and with free radicals results in the "trapping" of the radical, forming a DMPO-R adduct (Paramagnetic), which can be observed in the EPR spectrum. EPR spectra were simulated using the computer program SpinSim (see Appendix).. 190

Figure 4-3. EPR spectrum of species formed upon reaction of potassium dichromate (5.0 mM chromium(VI)) with cysteine (5.0 mM) 192

Figure 4-4. EPR spectrum of species formed upon reaction of potassium dichromate (1.8 mM chromium(VI)) with cysteamine (5.45 mM) 194

Figure 4-5. EPR spectrum of species formed upon reaction of potassium dichromate (20.0 mM chromium(VI)) with cysteamine (20.0 mM) 196

Figure 4-6. EPR spectra of species formed upon reaction of potassium dichromate with ethanethiol in the presence or absence of DMPO (100 mM). 198

Figure 4-7. EPR spectra of species formed upon reaction of potassium dichromate with propanethiol in the presence or absence of DMPO (100.0 mM) 200

Figure 4-8. EPR spectra of species formed upon reaction of potassium dichromate with dimercaptosuccinic acid in the presence or absence of DMPO (100.0 mM). 202

Figure 4-9. EPR spectrum of species formed upon reaction of potassium dichromate (400.0 mM chromium(VI)) with glutathione (40.0-400.0 mM) 204

Figure 4-10. EPR spectrum of species formed upon reaction of potassium dichromate (20.0 mM chromium(VI)) with ascorbic acid (20.0 mM) 206

Figure 4-11. Computer simulation study of the radical species produced during the reaction of potassium dichromate (20.0 mM chromium(VI)) with ascorbic acid (20.0 mM) 208

Figure 5-1. EPR spectra of chromium(V) (A) and chromium(III) (B) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (50.0 mM chromium(V)) with b-mercaptoethanol (50.0 mM) 239

Figure 5-2. EPR spectra of chromium(V) (A) and chromium(III) (B) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM chromium(V)) with b-mercaptoethanol (5.0 mM) 241

Figure 5-3. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM chromium(V)) with b-mercaptoethanol (5.0 mM) 243

Figure 5-4. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM chromium(V)) with b-mercaptoethanol (5.0 mM) 245

Figure 5-5. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM chromium(V)) with b-mercaptoethanol (5.0 mM) 247

Figure 5-6. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM chromium(V)) with b-mercaptoethanol (10.0 mM) 249

Figure 5-7. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM chromium(V)) with b-mercaptoethanol (10.0 mM) 251

Figure 5-8. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM chromium(V)) with b-mercaptoethanol (100.0 mM) 253

Figure 5-9. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5 mM chromium(V)) with b-mercaptoethanol (500 mM) 255

Figure 5-10. Solution EPR spectra of chromium(V) complexes formed upon reaction of potassium perchromate, K3CrO8 (5.0 mM chromium(V)) with dithiothreitol (15.0 mM) 257

Figure 5-11. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with dithiothreitol (10.0 mM) 259

Figure 5-12. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM) with dithiothreitol (100.0 mM) 261

Figure 5-13. (A) Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with dithiothreitol (100.0 mM) 263

Figure 5-14. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with dithiothreitol (25.0 mM) 265

Figure 5-15. (A) Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with dithiothreitol (100.0 mM) 267

Figure 5-16. (A) Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with dithiothreitol (25.0 mM) 269

Figure 5-17. (A) Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with dithiothreitol (7.5 mM) 271

Figure 5-18. Time course of the g = 1.980 EPR signal observed during the reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with dithiothreitol (20, 5, or 1.5:1 dithiol:Cr ratio) 273

Figure 5-19. Comparison of the solution EPR spectra of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) in various solvents (50% acetic acid, acetonitrile, N,N-dimethylformamide, or methanol) at 25 °C. 275

Figure 5-20. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium dichromate (5.0 mM chromium(VI)) with dithiothreitol (25.0 mM) 277

Figure 5-21. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM) with glutathione (5.0 mM) 279

Figure 5-22. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (0.5 mM) with glutathione (5.0 mM) 281

Figure 5-23. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM) with glutathione (15.0 mM) 283

Figure 5-24. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with glutathione (100.0 mM) 285

Figure 5-25. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with glutathione (100.0 mM) 287

Figure 5-26. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with oxidized glutathione (50.0 mM) 289

Figure 5-27. Frozen solution (77K) EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with oxidized glutathione (50.0 mM) 291

Figure 5-28. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (5.0 mM) with glycine (5.0, 50.0, or 500.0 mM) 293

Figure 5-29. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (4.0 mM) with oxalic acid (200.0 mM) 295

Figure 5-30. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (4.0 mM) with oxalic acid (200.0 mM) 297

Figure 5-31. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-hydroxy-2-methylbutyrato)oxochromate(V) (4.0 mM) with oxalic acid (200.0 mM) 299

Figure 5-32. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (4.0 mM) with oxalic acid (200.0 mM) 301

Figure 5-33. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with oxalic acid (1.0 M) 303

Figure 5-34. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with ascorbic acid (2.5 mM) 305

Figure 5-35. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with ascorbic acid (100.0 mM) 307

Figure 5-36. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with thioglycolic acid (2.5 mM) 309

Figure 5-37. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with thioglycolic acid (5.0 mM) 311

Figure 5-38. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with thioglycolic acid (100.0 mM) 313

Figure 5-39. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with thioglycolic acid (100.0 mM) 315

Figure 5-40. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with thioglycolic acid (100.0 mM) 317

Figure 5-41. Solution EPR spectra of chromium(V) complexes formed upon reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with thioglycolic acid (100.0 mM) 319

Figure 5-42. Electronic spectra of the reaction of sodium bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) (5.0 mM) with thioglycolic acid (100.0 mM) 321

Abbreviations

b-ME, b-mercaptoethanol; CT-DNA, calf thymus DNA; CYS, cysteine; DETAPAC, diethylenetriaminepentaacetic acid; DES, deferoxamine mesylate; dGMP, deoxyguanosine monophosphate; dGTP, deoxyguanosine triphosphate; DMF, N,N'-dimethyl formamide; DMPO, 5,5-dimethyl-1-pyrroline-N-oxide; DMSA, dimercaptosuccinic acid; DNA-P, DNA nucleotide; DPPH, 2,2-diphenyl-1-picrylhydrazyl radical; DTT, dithiothreitol; E°', reduction potential at pH 7.4 extrapolated from standard conditions using the Nernst equation; EDTA, ethylenediaminetetraacetic acid; ehba, 2-ethyl-2-hydroxybutyric acid; EPR, electron paramagnetic resonance; GSH, glutathione; GSSG, oxidized glutathione; HEPES, N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; hmba, 2-hydroxy-2-methylbutyric acid; salen, N,N'-ethylenebis(salicylideneiminato); poly(dA), poly deoxyadenosine; poly(dC), poly deoxycytosine; poly(dG), poly deoxyguanosine; Tris-HCl, Tris-(hydroxymethyl)aminomethane hydrochloride.